58th Annual William J. Holloway Infectious Disease Symposium

58th Annual William J. Holloway Infectious Disease Symposium 

Monday, May 3, 2021 to Friday, May 7, 2021; 12:00pm - 1:00pm

Virtual Event



Target Audience

This activity is intended for primary care physicians, speacialty physicians, pharmacists, residents, medical students, physician assistants, nurses, and nurse practitioners.

Statement of Need

Prescribers continue to practice poor  antibiotic stewardship.  They prescribe antibiotic regimens that are too long and too broad.  This leads to complications and resistance.Caregivers are unaware of new guidelines in  antimicrobial stewardship. Caregivers need a better understanding of novel presentations of infection in immuno-compromised hosts. 

Educational Objectives

Upon completion of this activity learners should be able to:

  1. Explain that "shorter is better" when it comes to antibiotic durations.
  2. Discuss the importance of critical physical exam signs and historical clues to infection in immuno-compromised hosts as well as novel treatment strategies.  
  3. Discuss effective discharge strategies that embrace both patient safety and value, shortening duration of hospital stay for these patients.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and ChristianaCare. The Medical Society of Delaware (MSD) is accredited by the ACCME to provide continuing medical education (CME) for physicians.

It is the policy of the Medical Society of Delaware to comply with the ACCME Standards for Commercial Support of Continuing Medical Education. In keeping with these standards, all faculty participating in continuing medical education provided by MSD are expected to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations.

Joint providership of CME by MSD in no way implies endorsement of any product or service. 

This activity is not supported by commercial funding.

Credit Designation Statement

The Medical Society of Delaware designates this live activity for a maximum of 5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner or significant other, currently or within the last 12 months) with commercial interests. Accredited providers are required to provide this information to learners before the start of an activity.

The following is a list of the faculty, along with any information they have disclosed regarding their relevant financial relationships.

David M. Cohen, MD (Planner, Activity Director, Moderator) - No Disclosures
Marykay Ennis, MBA (Planner, Coordinator) - No Disclosures
Chad  Duffalo, MD, MPH (Planner) - No Disclosures
Omar Khan, MD, MHS (Planner) - No Disclosures
John Donnelly, MD (Planner) - No Disclosures
Nicole Harrington, PharmD (Planner) - Gilead
(honorarium for role on advisory board) - The financial relationship does not relate to the educational assignment/presentation.
Heather Ragozine-Bush, MD (Planner) - No Disclosures

Lisa V. Adams, MD (Speaker) - 
Oxford Immunotec (consultant fee for Presentation at IDSA conference) - The financial relationship does not relate to the educational assignment/presentation.

Steven Gordon, MD (Speaker) - No Disclosures

Kieren Marr, MD, MBA (Speaker)
- Cidara, Sfunga, Pulmocide, Merck  income from consulting); MycoMed (IP rights, ownership rights - management position) - All scientific data referenced or used as justification of patient care recommendations conforms to the generally accepted standards of experimental design, data collection, and analysis.

Brad Spellberg, MD (Speaker) -  GSK (consulting fee for lecture), IQVIA/PPD (DSMB fee for chairing COVID trial), ExBaq, BioAim (equity as founder of start ups) - the financial relationships do not relate to the educational assignment/presentation. Best avialable published evidence will be used to support the presentation. All scientific data referenced or used as justification of patient care recommendations conforms to the generally accepted standards of experimental design, data collection, and analysis.

Robert D. Hicks, PhD (Speaker) - No Disclosures



All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this education. No single reference or service can take the place of medical training, education and experience. This educational activity does not define a standard of care, nor is it intended to dictate an exclusive course of management. This information should not substitute for a visit or consultation with a health care provider.

Technical Requirements

This activity is best experienced using the most current browser of Firefox, Chrome, Safari, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.

Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.